首页|University of Toronto Dalla Lana School of Public Health Reports Findings in Mental Health Diseases and Conditions (Factors associated with the use of psychedelics, ketamine and MDMA among sexual and gender minority youths in Canada: a machine ...)
University of Toronto Dalla Lana School of Public Health Reports Findings in Mental Health Diseases and Conditions (Factors associated with the use of psychedelics, ketamine and MDMA among sexual and gender minority youths in Canada: a machine ...)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
Bmj Publishing Group
New research on Mental Health Diseases and Conditions is the subject of a report. According to news reporting from Toronto, Canada, by NewsRx journalists, research stated, “Substance use is increasing among sexual and gender minority youth (SGMY). This increase may be due to changes in social norms and socialisation, or due to SGMY exploring the potential therapeutic value of drugs such as psychedelics.” Financial support for this research came from Canadian Institutes of Health Research. The news correspondents obtained a quote from the research from the University of Toronto Dalla Lana School of Public Health, “We identified predictors of psychedelics, MDMA and ketamine use. Data were obtained from 1414 SGMY participants who completed the ongoing longitudinal 2SLGBTQ+ Tobacco Project in Canada between November 2020 to January 2021. We examined the association between 80 potential features (including sociodemographic factors, mental health-related factors and substance userelated factors) with the use of psychedelics, MDMA and ketamine in the past year. Random forest classifier was used to identify the predictors most associated with reported use of these drugs. 18.1% of participants have used psychedelics in the past year; 21.9% used at least one of the three drugs. Cannabis and cocaine use were the predictors most strongly associated with any of these drugs, while cannabis, but not cocaine use, was the one most associated with psychedelic use. Other mental health and 2SLGBTQ+ stigmarelated factors were also associated with the use of these drugs. The use of psychedelics, MDMA and ketamine among 2SLGBTQ+ individuals appeared to be largely driven by those who used them together with other drugs. Depression scores also appeared in the top 10 factors associated with these illicit drugs, suggesting that there were individuals who may benefit from the potential therapeutic value of these drugs.”
TorontoCanadaNorth and Central AmericaAnalgesicsAnestheticsCentral Nervous System AgentsCyborgsCyclohexanesDrugs and TherapiesEmerging TechnologiesEpidemiologyGender HealthGender and HealthGeneral AnestheticsHealth and MedicineHydrocarbonsKetamineKetamine TherapyMachine LearningMental Health Diseases and ConditionsPharmaceuticalsWomen’s Health
NETL
NSTL
Bmj Publishing Group
